Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sirius XM Holdings Inc (SIRI) vs TransMedics Group Inc (TMDX) Price & Performance

Sirius XM Holdings IncTrade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

Sirius XM Holdings Inc vs TransMedics Group Inc — how do they compare? Sirius XM Holdings Inc trades at $30.24 (market cap $10.30B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Sirius XM Holdings Inc is far larger — about 4.1× TransMedics Group Inc's market cap, and Sirius XM Holdings Inc pays a 3.53% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.

SIRITMDX
Market Cap
$10.30B$2.54B
Sector
MediaTechnology
52-Week High
$31.22$150.42
52-Week Low
$19.92$61.99
Enterprise Value
$19.97B$2.94B
Dividend Yield
3.53%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Sirius XM Holdings Inc

SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.

Read more on SIRI

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX